Amanote Research
Register
Sign In
Sustained Durability and Tolerability of Etanercept in Ankylosing Spondylitis for 96 Weeks
Annals of the Rheumatic Diseases
- United Kingdom
doi 10.1136/ard.2004.035105
Full Text
Open PDF
Abstract
Available in
full text
Categories
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Date
August 26, 2005
Authors
J C Davis
Publisher
BMJ
Related search
Sustained Response to Anakinra in Ankylosing Spondylitis
Rheumatology
Rheumatology
Pharmacology
Sustained Improvements in Workplace and Household Productivity and Social Participation With Certolizumab Pegol Over 96 Weeks in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Effects of Etanercept and Infliximab on Bone Metabolism Indexes in Patients With Ankylosing Spondylitis
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
The Association ofNLRP3andTNFRSF1Apolymorphisms With Risk of Ankylosing Spondylitis and Treatment Efficacy of Etanercept
Journal of Clinical Laboratory Analysis
Allergy
Immunology
Biochemistry
Public Health
Medical Laboratory Technology
Clinical Biochemistry
Hematology
Microbiology
Environmental
Occupational Health
Ankylosing Spondylitis
Ankylosing Spondylitis
Ankylosing Spondylitis
Ankylosing Spondylitis
Symptomatic Therapy for Ankylosing Spondylitis
Modern Rheumatology Journal
